RICWR Patient Compensation

Participants in clinical trials as patients are compensated for their time that is completely opposite to regular physician who takes money from patients. Researchers in clinical research trials spend most of their time with their patients to educate and teach them in order to deliver more comprehensive healthcare and pay the patients in advance.

There are certain rules and a balancing act between two things as coercion issue and respect for the time, cost and travel of patients that patients spend to be able to be in research trials.


Research is very appropriately governed from the ethics perspective by the groups that are called IRBs (Institutional review boards). IRBs are responsible to make sure that pharmaceutical company is paying huge amount of money to patients as they are buying their time and getting them into trials in a forcible manner. This creates a limitation to compensate their patients.

Time is costly and worthy:

In research trials, delivering more healthcare means to take more time of the patients in order to perform more labs, EKGs, physical exams and tests that takes no less time than other practice settings. This time of the patients is worth something and costly.

Pharmaceutical industries compensate their patients to participate in research trials as follow:

1.     Compensation for the time patients spends with the researchers in their office.

2.     Compensation for the travel and other expenses to participate in clinical research trials.

Patients are paid according to their time they spend in the office with physicians for examination.


Leave a Comment

Please fill the form below to post a comment.